Inhibition of 11β-HSD1 has demonstrated potential in the treatment of various components of metabolic syndrome. We wish to report herein the discovery of novel azabicyclic sulfonamide based 11β-HSD1 inhibitors. Highly potent compounds exhibiting inhibitory activities at both human and mouse 11β-HSD1 were identified. Several compounds demonstrated significant in vivo activity in the mouse cortisone
已证明抑制11β-H
SD1具有治疗代谢综合症各个组成部分的潜力。我们希望在此报告发现新型基于
氮杂双环磺酰胺的11β-H
SD1
抑制剂。鉴定出对人和小鼠11β-H
SD1均表现出抑制活性的高效化合物。几种化合物在小鼠
可的松激发试验中显示出显着的体内活性。